ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 688235 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 688235; 2) Community: the network communities that were significantly associated with the response to NSC 688235; 3) Molecule: the relationships between components within communities and NSC 688235; 4) MDR: the compounds that were significantly associated with the NSC 688235.

NSC Compound Enrichment Correlation
NSC 120925 Null 0.049100146992119 0.27602484
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.049100146992119 -0.032805729
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.049100146992119 0.0072114846
NSC 176328 Ellipticine, 6-(3-aminopropyl)-, dihydrochloride 0.049100146992119 0.2086176
NSC 261726 ICN 4221 0.049100146992119 0.063399146
NSC 287069 Epicorazine A 0.049100146992119 0.097250647
NSC 319947 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- 0.049100146992119 0.39499481
NSC 326061 1-Piperidinecarbothioic acid, 2-ethyl-, [1-(2-pyridinyl)ethylidine]hydrazide 0.049100146992119 0.084426644
NSC 330507 Tanespimycin 0.049100146992119 0.16853983
NSC 350629 2-Propen-1-one, 2-[(dimethylamino)methy]-1-(4- .beta.-D-glucopyranosyloxyphenyl)-, tetraacetate ester 0.049100146992119 0.12237612
Total:137  Current:124    [First] [Prev] [Next] [Last]